Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Hoogleraar Global Health Economics UMCG & RUG (Medische en Economie & Bedrijfskunde faculteiten)
Profielfoto van prof. dr. M.J. (Maarten) Postma
Telefoon:
050 361 5084 (secretariaat)
E-mail:
m.j.postma rug.nl

Publicaties

A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands

Cost-Effectiveness Analysis of Mammography-Based Breast Cancer Screening in Indonesia

Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy

Early economic evaluation of chelation therapy in kidney transplant recipients with high-normal lead

Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021

Long-term effectiveness of a digital inhaler on medication adherence and clinical outcomes in adult asthma patients in primary care: the cluster randomised controlled ACCEPTANCE trial

Lung cancer screening with volume computed tomography is cost-effective in Greece

Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study

Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America

A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons

Pers/media

Maarten Postma: Cost-effectiveness is stick for Big Pharma

The Office of Health Economics

The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-